Lv42
450 积分 2023-07-25 加入
Docetaxel-related side effects and their management
20小时前
已完结
Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations
14天前
已完结
AM Last Page
14天前
已关闭
Residual tumor characteristics of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy
14天前
已完结
Tislelizumab combined with nab‐paclitaxel and cisplatin as the more effective chemoimmunotherapy strategy in the neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma: A prospective, two‐cohort, phase 2 trial
20天前
已完结
Atezolizumab Plus nab-Paclitaxel in the Treatment of Metastatic Triple-Negative Breast Cancer With 2-Year Survival Follow-up
29天前
已完结
Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial
1个月前
已完结
Immune Checkpoint Inhibitor Toxicity in 2018
2个月前
已完结
A randomised phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in advanced squamous cell lung carcinoma (C-TONG1002)
2个月前
已完结
Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update
2个月前
已完结
皖公网安备34019202002308
